1 School of Biochemistry and Microbiology, University of Leeds, Leeds LS2 9JT, UK; 2 Department of Microbiology, The General Infirmary at Leeds, Leeds LS1 3EX; 3 Mutation Detection Facility, Cancer Research UK, Ashley Wing, St Jamess University Hospital, Leeds LS9 7TF, UK
![]() |
Abstract |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Keywords: dental prescribing, oral flora, prophylaxis, diagnostic laboratories
![]() |
Introduction |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
The relationship between antibiotic use and resistance is complex. A population genetics study demonstrated that the volume of drug use can influence the selection pressure for antibiotic resistance, but a quantitative relationship between these two factors was not demonstrated.2 Reduction in antibiotic resistance can only occur following a significant reduction in antibiotic use. It has been argued that the time required for a drop in the prevalence of antibiotic resistance to occur will be more than the time required for resistance to develop under a constant selective pressure.2
An important factor influencing the emergence of resistance in a bacterial population is the selective pressure applied by antibiotics. Exposure of oral bacteria to low concentrations of minocycline has led to the emergence of strains that show reduced susceptibility to this drug.3 Thus, the concentration that antibiotics can achieve in the oral cavity may be critical in selecting resistant bacteria within the oral flora. Making a choice of antibiotic to treat oral infections taking into consideration the concentrations that various drugs may achieve, however, is not straightforward. Many ß-lactam antibiotics achieve very low concentrations in saliva in comparison with the concentration that is attained in serum, but the level of susceptibility for oral streptococci is such that the low saliva concentration does not cause problems.4,5 Similarly, erythromycin does not reach as high a concentration in saliva as in serum.6,7 In contrast, the concentration of azithromycin found in saliva is significantly higher than is found in serum,8,9 but in the management of dental infection, azithromycin has been shown to depress concentrations of a non-steroidal anti-inflammatory drug in periodontal tissue, administered for pain relief.10 Thus, the choice of which antibiotic to prescribe is not simply a matter of picking the drug with the greatest antimicrobial activity.
In medical practice, a low correlation between community prescribing and antibiotic resistance to urinary coliforms and Streptococcus pneumoniae was illustrated in a cross sectional study involving 405 general practices in southwest and northwest England.11 However, that study used overall prescriptions as a crude measure for population exposure; social interactions were not examined. General medical practitioners are responsible for 80% of antimicrobial prescribing in the UK.1 It has been demonstrated that most of the antibiotics are prescribed in the community and that the majority of prescribing was for conditions including otitis media, upper respiratory tract infection, bronchitis, pharyngitis and sinusitis.12 These are infections associated with microorganisms found in the oropharynx. The majority of prescriptions written in the community are written by general medical practitioners, and the drugs prescribed will have a significant impact on the selection of resistance among bacteria in the oral flora. Nevertheless, the role of dental prescribing in the selection of resistant bacteria is an area that has received relatively little attention. This review seeks to address this deficit.
![]() |
The oral flora |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
A complex ecosystem is formed in the oral cavity, and it changes constantly throughout life. Many commensal microorganisms will cause disease if provided with appropriate conditions. Gram-positive aerobic cocci, -haemolytic streptococci, peptostreptococci and Gram-negative anaerobes are frequently isolated from oral infections.18 The role of general dental practitioners in selecting and maintaining antibiotic resistance is unclear. Thus, general dental practitioners may be unsure how to attend to this potential problem.
![]() |
Resistance to amoxicillin, penicillin and metronidazole in the oral flora |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Aminopenicillins
Aminopenicillins are one of the three antibiotic types most commonly prescribed in dentistry.23 Amoxicillin resistance has been described in Veillonella spp. and Prevotella denticola isolated from root canals. In one study, all 34 strains of facultative anaerobic bacteria isolated from the same root canals were susceptible to amoxicillin, as were 52 of 54 (96%) strains of obligate anaerobes.24 The NCCLS agar dilution method was used and the breakpoint for amoxicillin was 8 mg/L. The results of this study suggest that resistance to amoxicillin is not widespread among anaerobes that inhabit deeper sites in the oral cavity. Fosse et al.25 demonstrated susceptibility of Gram-negative bacilli such as Prevotella to amoxicillin when combined with clavulanic acid, although this group did report that at least one Prevotella sp. strain producing ß-lactamase was found in 53.2% of patients and 39.4% of the periodontal pockets that they investigated. These reports are inconclusive, and further study is required to clarify the prevalence of resistance to aminopenicillins. This may prove problematic to achieve because of the difficulties associated with antimicrobial susceptibility testing for anaerobes. There are no standardized methodologies agreed, and reproducible results are difficult to achieve.
Penicillins
In 1986, streptococci producing ß-lactamase were isolated from the subgingival plaque of adults with periodontitis.26 Production of ß-lactamase is, however, uncommon for most streptococci, where resistance is typically mediated by alterations to the penicillin-binding proteins.2729 Susceptibility tests on 207 isolates of nine species of -haemolytic streptococci, including Streptococcus mutans, Streptococcus salivarius, Streptococcus oralis and Streptococcus mitis, found that only S. mutans was universally susceptible to penicillin.30 Potgieter et al.31 report four blood culture isolates of S. mitis that were resistant to penicillin (MICs 1632 mg/L); they were also resistant to the aminoglycosides gentamicin, kanamycin and tobramycin. S. mutans is cariogenic, and several studies have reported on its susceptibility to penicillin and other antimicrobials.3235
In a study investigating the susceptibility of 424 isolates of S. mutans taken from 116 children and students, all bacteria were found to be susceptible to penicillin, as well as to amoxicillin, trimethoprim, tetracycline and erythromycin.35 In another study, 839 isolates of S. mutans from 209 patients were equally susceptible to penicillin in patients exposed and not exposed to dental amalgam fillings.33 Mercury in dental amalgam did not select for antibiotic resistance.36,37 Ninety-four percent of 41 strains of S. mutans isolated from patients with endocarditis had MICs of 0.08 mg/L for penicillin, only 68% had minimum bactericidal concentrations (MBCs) of penicillin
0.08 mg/L. High-level penicillin resistance (MIC
4 mg/L) was shown in 8% of S. salivarius strains, 20% of S. mitis strains and 35% of S. oralis strains.30 Compared with other studies, however, this level of resistance is low. MICs of benzylpenicillin for S. oralis and S. mitis range from 32 to 64 mg/L.38,39 S. oralis and S. mitis show the highest penicillin resistance amongst the
-haemolytic streptococci. Although the degree of resistance is variable, it is consistently present in bacteria isolated from the oral cavity.
The high levels of resistance that are now being demonstrated in the -haemolytic streptococci are a cause for concern. There is evidence to show that interspecies transfer of resistance determinants occurs between S. pneumoniae and other
-haemolytic streptococci.38,39 The resistance determinants transferred from S. pneumoniae are mosaic genes, containing regions with nucleotide sequences very similar to those from strains susceptible to penicillin interspersed with regions of nucleotide sequence divergence, which confer resistance.40 These related sequences have been identified in S. sanguis, S. oralis and S. mitis, indicating interspecies transfer.4043
Porphyromonas gingivalis, Prevotella intermedia and Prevotella nigrescens are common isolates from oral infections. Antibiotic susceptibility testing of strains of these bacteria from patients in Spain found P. gingivalis strains producing ß-lactamase have been isolated infrequently from periodontal pockets.44,45 The occurrence of penicillin resistance is a more consistent finding in Prevotella spp.46,47 No significant difference in the presence or degree of penicillin resistance has been demonstrated between pigmented and non-pigmented species in this genus.44 Despite the small numbers reported by these authors, their studies indicate that surveillance of these species is important.25,47
Other oral anaerobes implicated in infection include members of the genera Fusobacterium and Veillonella; these bacteria have been associated with penicillin resistance.39,48,49 In one study, 31% of fusobacteria isolated from odontogenic abscesses were found to produce ß-lactamase.50 Other workers are recommending clindamycin for the first-line treatment of odontogenic infections because of the problems of ß-lactamase production amongst the bacteria that cause this polymicrobial condition.51 In that study, resistant bacterial strains were isolated more frequently from patients who had recently received penicillin treatment than from patients who had not received recent antibiotic treatment.
Metronidazole
Dentists are the most frequent prescribers of metronidazole.1 However, the emergence of resistance to this drug may be slower than if it were used alone, because in order to target both aerobic and anaerobic organisms, metronidazole is used empirically in combination with one or more antibiotics, although resistance to the drug may be associated with mobile genetic elements, aiding spread.52
Possible mechanisms of resistance to metronidazole include mutations in the enzymes responsible for reduction of the drug to its active form, mutations resulting in decreased entry of the antibiotic into the cell and mutations to transporters causing efflux of the drug.53 Roche & Yoshimori54 found that eight out of 97 isolates from odontogenic abscesses were resistant to metronidazole. These included five isolates of Lactobacillus spp., two isolates of Gemella morbillorum and an isolate of Actinomyces israelii. All other anaerobes associated with odontogenic abscesses in this study were susceptible to metronidazole. These included Prevotella spp., Peptostreptococcus spp., Bacteroides spp. and Porphyromonas spp., all of which have been previously implicated in odontogenic disease. Lana et al.24 isolated 54 obligate anaerobes from the root canals of Brazilian patients, and found 52/54 (96.3%) were susceptible to metronidazole. There were only two resistant isolates: Clostridium butyricum and a member of the genus Veillonella. P. denticola was resistant to every antimicrobial tested, with the exception of metronidazole. Of the facultative anaerobes tested 17/34 (50%) were inhibited by metronidazole when tested anaerobically. This is not surprising, owing to the heterogeneous behaviour of these microorganisms, being capable of metabolism under anaerobic and aerobic conditions; a crucial step in the activity of metronidazole is the reductive activation of the nitro group on the drug. This converts it from an inactive prodrug to a nitroso free-radical form, which is cytotoxic.
Eick et al.50 determined the susceptibility of isolates from periodontal and odontogenic abscesses to a variety of antibiotics used in their treatment, including metronidazole. The capnophiles Eikenella corrodens and Actinobacillus actinomycetemcomitans were resistant to metronidazole, owing to an intrinsic resistance mechanism.50 This observation is supported by Madinier et al.,55 who studied the susceptibility of A. actinomycetemcomitans to various antimicrobials. This bacterium is an important factor in intractable periodontal disease, often leading to early loss of permanent teeth. Of 50 strains tested, 72% were resistant to metronidazole at the chosen breakpoint (16 mg/L). An MIC90 of 128 mg/L was recorded for their isolates.
The presence of, or potential for, metronidazole resistance has not been widely investigated. This is probably because the few studies that have been conducted have found a high prevalence of susceptibility to metronidazole among anaerobes, although there has been a report of subdural empyema caused by Prevotella loescheii with reduced susceptibility to metronidazole, the MIC of one isolate being 12 mg/L.56 Increasing resistance to metronidazole among isolates of Helicobacter pylori57 and the anaerobic protozoa58 is being reported.
![]() |
Resistance to other antimicrobial agents in the oral flora |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
As with penicillins, the -haemolytic streptococci show high resistance to cephalosporins, with MICs as high as 128 mg/L for cefotaxime.39 High MICs have also been reported for first- and second-generation cephalosporins. High-level cefotaxime resistance was easily transferred in the laboratory to less resistant S. pneumoniae, a process that is thought to occur in nature, although dental practitioners do not prescribe cefotaxime, since it is administered parenterally.38 Changes in three penicillin-binding proteins accompanied the transfer of the high-level cefotaxime resistance determinant.38 Entercoccus spp., isolated from root canal exudates of periodontal patients, have expressed high-level resistance to cephalosporins, more so than other isolates including Gram-negative bacteria.59 Outside of the laboratory, the rate of transfer may be low, but there is a potential for greater transfer with increasing selection pressure due to more frequent antibiotic exposure.
In a recent study, staphylococci from the oral cavity were all found to be susceptible to cephalosporins,60 although an older study reported the presence of methicillin-resistant S. aureus in the oral cavity,61 and this bacterium is notably difficult to eradicate from the oropharynx.62 Peptostreptococci have also shown susceptibility to cephalosporins.44 Kuriyama et al.44 found that bacteria of the genus Porphyromonas and of the genus Fusobacterium showed susceptibility to cephalosporins, although fourth-generation cephalosporins were found to have higher MIC50s and MIC90s than older cephalosporins. This suggests that cephalosporins may be used inappropriately. Conversely, Eick et al.50 found the nearly one-third of Fusobacterium spp. and one-third of Veillonella spp. were resistant to cefoxitin. Kuriyama et al.44 found that a range of Prevotella species were resistant to a range of cephalosporins.
Resistance to ß-lactams such as penicillins and cephalosporins is found in the oral flora, but the prevalence and degree of resistance is unclear. The potential to pass high-level resistance to S. pneumoniae makes it particularly important that the prevalence is determined with greater accuracy than is currently the case.
Tetracyclines
Mechanisms by which bacteria resist tetracycline include the synthesis of efflux proteins, production of ribosome protection proteins and enzymatic modification of the antibiotic. Tetracycline resistance is encoded by tet genes, of which 27 have currently been described, most of which are found in oral species.53
Antibiotic profiling of -haemolytic streptococci isolated from the oropharynx of healthy Greek children showed 23% of isolates were resistant to tetracycline;63 the majority of isolates were S. mitis. Konig et al.39 also found two high-level tetracycline-resistant isolates of S. mitis.
Okamoto et al.64 studied the prevalence of black-pigmented anaerobes of the genus Porphyromonas and of Prevotella spp., and the distribution of the tet(Q) gene amongst them. Of P. nigrescens, 46/167 (27.5%) isolates harboured tet(Q), as did three of 47 (6.4%) isolates of P. intermedia. In a separate study, 21% of P. intermedia isolates carried the tet(Q) gene, whereas only 15.2% of P. nigrescens carried the tet(Q) gene.65 Contrary to the previous study, three of five (60%) P. gingivalis isolates also carried tet(Q), but this was in combination with the erythromycin resistance determinant erm(F).
Carriage of both tet(Q) and erm(F) is common.6668 Chung et al.69 found 34 isolates of black-pigmented anaerobes, including Bacteroides fosythus, carrying both genes. Tetracycline resistance is also a frequent co-marker in penicillin-resistant oral strains.70,71 Fosse et al.25 found resistance to tetracycline frequently associated with ß-lactamase production, with 50% of Gram-negative oral anaerobes isolated resistant both to tetracycline and to penicillins. Madinier et al.55 found 4% of A. actinomycetemcomitans strains tested were resistant to tetracycline at the breakpoint of 8 mg/L; the MIC90 of tetracycline was 4 mg/L.
Tetracycline resistance is widespread. Furthermore, tetracyclines are used infrequently in dental practice because of the side-effects associated with this family of drugs, which can affect tooth colour.72 Association of resistance to tetracyclines with penicillin and erythromycin resistance makes the high prevalence of tetracycline resistance potentially dangerous. Its presence may facilitate the dissemination of other resistance determinants.65,7375
Macrolides and related antibiotics
Resistance to erythromycin is most commonly due to the acquisition of one of 21 erm genes. These code for rRNA methylases that bring about methylation of adenine residues in 23S rRNA, preventing the binding of macrolides to the 50S ribosomal subunit. Other mechanisms by which bacteria express macrolide resistance include drug inactivation by an enzyme encoded by mph, and efflux of macrolides by an ATP-binding transporter encoded by msrA found in S. aureus.53 Low-level macrolide resistance in the oral flora may also be associated with the expression of genes in the mef family, encoding another efflux pump.76,77
Ioannidou et al.63 studied macrolide resistance in oral -haemolytic streptococci in healthy Greek children. Of 200 isolates, 77 (38.5%) were resistant to erythromycin, the macrolide most commonly used in dentistry, and 67 (33.5%) isolates were resistant to clarithromycin. Although the prevalence of resistance to each drug was similar, the MIC90 for erythromycin was twice that of clarithromycin. With 53% of isolates being resistant, S. oralis isolates showed the highest prevalence of resistance to erythromycin, followed by S. salivarius and S. sanguis, with 48% and 44% of isolates resistant to this drug, respectively.
A study by Sefton78 in 1999 demonstrated the presence of resistant flora and the changes in the oral flora on administration of macrolides to patients with periodontal disease. Periodontal patients were subdivided into a treatment group and placebo group. The treatment group received the azalide, azithromycin. The total number of organisms recovered during sampling remained constant throughout the study but, as was shown in a similar study using tetracycline,74 this was due to the replacement of susceptible organisms with a resistant population. Resistant streptococci increased significantly compared with the placebo group, and remained at raised levels for up to 3 months after treatment. These bacteria also showed cross-resistance to other macrolides.78 This shows longer lasting effects compared with a similar study performed in the laboratory with tetracycline, where high level resistance was maintained for only 8 h.74
Macrolide resistance in oral anaerobes often occurs in conjunction with tetracycline resistance. Sanai et al.65 investigated the antibiotic resistance of P. gingivalis, P. intermedia and P. nigrescens. Carriage of erythromycin resistance genes alone and tetracycline resistance genes alone was similar in all of the strains. An equal proportion of P. intermedia isolates carried erm(F) alone or tet(Q) alone (21% each, respectively). This is also seen in other Prevotella species.65
The recent study on the effect on oral biofilms of a single pulse of tetracycline demonstrated the relationship between tetracycline and erythromycin resistance.74 Of the isolates resistant to tetracycline, 67% were also resistant to erythromycin. A single pulse of tetracycline selected for erythromycin-resistant isolates, as shown by the increase in the proportion of such isolates in the biofilms from 5% to 28%.74
Andres et al.47 were able to link erythromycin and tetracycline resistance and ß-lactamase production in Gram-negative anaerobes, concluding that they were associated with conjugative elements in oral Prevotella species. The co-transfer of resistance determinants to these three antibiotic classes occurs frequently within this genus, although the mechanism by which this happens has not been elucidated fully.
Chlorhexidine
Chlorhexidine is used widely by dentists and doctors as an antibacterial agent. Reports of S. aureus and Streptococcus sanguis using in vitro studies suggest problems with potential use owing to the emergence of resistance, which may be plasmid mediated.7981 Susceptibility testing in vitro of chlorhexidine against 141 isolates of S. mutans demonstrated that the MIC of chlorhexidine was 1 mg/L.35 Resistance to chlorhexidine in S. mutans and Streptococcus sobrinus was absent following the application of chlorhexidine for 1 week; three different chlorhexidine applications, chlorhexidine varnish, chlorhexidine fluoride varnish and chlorhexidine fluoride gel, were given to 58 individuals, and the MIC of chlorhexidine against 863 isolates of S. mutans was
1 mg/L and against 53 isolates of S. sobrinus was
2 mg/L.34
![]() |
Antibiotic prescribing by general dental practitioners |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Therapeutic antibiotic prescribing
Sixteen years ago, dentists in a teaching hospital in Manchester were found to be giving too many prescriptions and performing too few surgical procedures.84 In that study, indications for antibiotic prescribing were based on guidelines published by Cawson & Spector.85 These guidelines required the proven presence of infection with a bacterial rather than a viral aetiology, which was thus likely to respond to antibacterial chemotherapy. The infection itself had to be severe enough to justify treatment. Alternatively, treatment would be justified if its use would prevent a serious infection, such as bacterial endocarditis. Lastly, the guidelines stated that antibiotics should only be used where no alternatives, including surgery, were available. In the Manchester study,84 153/192 patients (80%) were prescribed antibiotics as treatment for dental and oral infections, and 39/192 (20%) for prophylaxis. The most frequent antibiotic prescribed for infection was penicillin V (60% of total prescriptions); erythromycin (14%), amoxicillin (12%) and metronidazole (8%) were prescribed less frequently. Tetracycline was not prescribed. Amoxicillin accounted for 66% of prescriptions for prophylaxis.
Most dental infections can be treated successfully by removal of the source.84,86 The majority of patients are, nevertheless, treated with antibiotics. A tendency to use antimicrobial treatment before resorting to dental extraction has been found. Only 25% of the 192 patients studied by Barker & Qualtrough84 were treated first by dental extraction.
Results from subsequent studies have not challenged these conclusions. An analysis of a random 10% of prescriptions written by dentists in Scotland between May and October 1998 revealed evidence of poor prescribing practices.20 Amoxicillin, metronidazole and penicillin V accounted for 90% of prescriptions, showing no great change in antibiotic choice since 1987. A range of 17 different antibiotics was prescribed. The doses were in accordance with recommendations in the Dental Practitioners Formulary,83 but there was wide variation in the frequency and duration. For example, prescriptions of amoxicillin in capsule formulation, which represented 73% of amoxicillin prescriptions, ranged from 2 to 20 days treatment. Only 39.1% of tetracycline prescriptions were correctly prescribed, at 250 mg.
Palmer et al.21 conducted a similar study in England and found that 5.6% of prescriptions were for combinations of antibiotics, the most frequent combination being amoxicillin and metronidazole. This is not surprising, because of the polymicrobial nature of many dental infections. Recent guidelines published by the Commission of the Federation Dentaire Internationale, however, recommend that combination therapy should be avoided whenever possible in dentistry.87 This recommendation was prompted by the wide variation in frequency and duration of antibiotic course and dose, with only 8.2% of prescriptions for penicillin V as recommended by the Dental Practitioners Formulary21 for most infections.
The Commission of the Federation Dentaire Internationale recommends that therapeutic antibiotics be given at a dose that will produce tissue concentrations higher than MIC for the pathogenic organisms implicated in the infection being treated.87 The duration of treatment should be sufficient to eliminate the pathogens, although it is now argued that short-duration therapy is the most effective method to prevent development of resistance.87 The choice of antibiotic for treatment must be based either on the likely pathogens and their probable susceptibility, or the susceptibility of pathogens cultured from the infection.87 Other measures of antibiotic efficacy may also need consideration when choosing appropriate therapy. These include consideration of the ratio of the peak antimicrobial concentration at the site of infection to the MIC of the drug, the time that the concentration of drug at the site of infection is higher than its MIC against the pathogen(s) and the AUC/MIC ratio.88
Prophylactic antibiotic prescribing
The use of antibiotic prophylaxis is contentious in dental practice. Were infections to be caused by pathogens from the oral flora that are resistant to therapeutic agents, even if these occurred at sites that are remote from the oral cavity such as in cases of endocarditis, this would compromise management. This problem is now more than a theoretical possibility; Lonks et al.89 report a case of endocarditis caused by an isolate of S. mitis resistant to penicillin and cefotaxime, although it remained susceptible to vancomycin. The patient in this case had recently undergone several dental procedures and was given amoxicillin for prophylaxis. The occurrence of resistance determinants encoding high-level resistance is increasing in the -haemolytic streptococci; these provide an important gene pool that not only affects the oral flora, but also may complicate management of extra-oral infections.38,90,91
The antibiotics used for prophylaxis mirror those used for treatment. Amoxicillin, penicillin V and metronidazole are the most popular choices.22 Guidelines recommend using an antibiotic prior to surgery that will attain a high serum concentration by the time that surgery begins, and that will be maintained until after surgery.92,93 The same guidelines recommend a single high dose that is not to be continued after surgery.
The Commission of the Federation Dentaire Internationale published new guidelines in 1999, stating that prophylaxis before dental surgery is appropriate for patients at risk of infective endocarditis, for example those with prosthetic heart valves.87 Other conditions for which prophylaxis is considered appropriate include patients with facial fractures, compound skull fractures or cerebral rhinorrhoea, immunocompromised patients, patients who have recently received radiotherapy to head and neck, and patients who have prosthetic hips, ventriculoarterial shunts or bone grafts. When questioned, only 21.8% of practitioners consider prophylaxis necessary for patients who have recently undergone radiotherapy to the head and neck,22 but guidelines recommend prophylaxis in these cases since the blood supply is diminished following radiotherapy, making patients more susceptible to infection.93 Dentists should work under the guidance of cardiologists or other specialists in the determination of valvular dysfunction with at risk patients of this type.
Over 50% of dentists surveyed in England would seek specialist advice before administering prophylaxis to patients with HIV infection, although it is thought that they are no more at risk of complications following dental infection than the immunocompetent.22 Most guidelines recommend considering each case individually, assessing the patient and the procedure and balancing benefits and risks.87,93,94
There is controversy surrounding the use of antibiotics for dental prophylaxis. For example, there is little or no evidence that oral microorganisms are significantly responsible for infections in prostheses other than cardiac prostheses.94 The Working Party of the BSAC does not support the use of prophylaxis in these cases.95 Of 891 dentists surveyed in England, however, 25.2% said they would prescribe prophylaxis for patients with prosthetic joints.22
The American Heart Association recommends prophylaxis against infective endocarditis in cardiac patients only in dental procedures associated with significant bleeding.92 Such procedures include dental extractions, periodontal surgery and scaling. Reassuringly, the majority of dentists surveyed by Palmer et al.22 would all prescribe prophylaxis for patients with cardiac conditions undergoing these procedures. High-risk patients include those with prosthetic heart valves, previous bacterial endocarditis or complex cyanotic congenital heart disease. Patients with a past history of rheumatic fever without valvular dysfunction are at negligible risk of infective endocarditis. Of dentists surveyed, however, 40% said they would give prophylaxis to these patients.22
Infective endocarditis occurs in up to 50 people per million per year, and 40% exhibit no known risk factors.94 It has also been noted that cases of endocarditis involving oral microorganisms are related infrequently to dental treatment.96 Additionally, Longman & Martin93 affirm that the rate of post-surgical infection in dentistry is low. Are dentists, therefore, being unnecessarily cautious? Such caution may be necessary in this litigious era.93 The guidelines drawn up by the American Heart Association have been based on experience and relevant literature rather than randomized or controlled human trials.92 The use of prophylaxis is therefore based on careful prediction. Such prediction is not sufficiently accurate to prevent infectious complications. It is not surprising that dentists opt to err on the side of caution.
Evidence in the literature suggests that antibiotic prescribing by dentists is often inappropriate. The Dental Practitioners Formulary limits the number of antibiotics that dentists can prescribe to 13.83 The choice of antibiotic that a dental practitioner makes, because the range of options is limited, is less likely to be inappropriate. It may therefore be the dose, duration or frequency of antibiotic prescription that is inappropriate. Yet the development of resistance in the oral flora is not due solely to the prescribing habits of dentists, who are responsible for only a small proportion of the total prescription of antibiotics.
Dental prescribing by practitioners outside the dental profession
Patients may choose to seek treatment from medical practitioners before consulting a dentist, and general medical practitioners are more likely to prescribe antibiotics than are dentists for acute dental problems.97 A prospective cross-sectional study in May 1994 found this was the case in 41% of 500 consecutive patients attending the examination and emergency department of Cardiff Dental Hospital. Sixty of the 500 patients in that study were already receiving antibiotics when they attended the dental hospital.19 Of these, general dental practitioners prescribed for 55% of cases, general medical practitioners prescribed for 33% and hospital doctors prescribed for 8%. Thus, even for dental infections, prescribing is not the exclusive domain of dental practitioners; others are also prescribing antibiotics, which in turn adds to the selective pressure for resistance.
![]() |
Use of diagnostic microbiology laboratories by general dental practitioners |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
![]() |
Discussion |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
The literature suggests a significant contributing factor in the selection of resistance may be an unnecessary use of antibiotic prescriptions in dentistry. Studies conducted by Barker & Qualtrough,84 Thomas et al.,19 Roy & Bagg20 and Palmer et al.21,22,99 suggest inappropriate prescribing by dental practitioners. Although dental undergraduates are taught that most oral infections may be treated by surgical or mechanical means without the use of antibiotics,84 dentists are prescribing millions of pounds worth of antibiotics every year.82 The therapy used is typically empirical, employing broad-spectrum antibiotics. Furthermore, culture and susceptibility testing to aid diagnosis and the rational choice of antibiotic often do not precede prescription for dental infection.98 This means that antibiotics are being prescribed for a range of dental infections for which they may not be required. This inappropriate prescribing results in frequent exposure to broad-spectrum antibiotics, predisposing to selection of resistant strains. It is therefore hardly surprising that resistance is present in the oral flora, and has the potential to pose real problems in terms of morbidity, cost of care and future treatment choice.
This issue is contentious. The American Dental Association suggested that dentists are responsible prescribers of antibiotics and are unlikely to play a major role in the global problem of antibiotic resistance.101 The UK Department of Health take a different view: SMACs Path of Least Resistance1 lists dentists as contributors to the problem, along with medical practitioners, veterinarians and those involved in agriculture.
Further investigation is required to confirm the results that patients attending dental hospitals have already been prescribed antibiotics by their general practitioners.34 Examining prescriptions and prescribing practices of dentists alone, however, may not be sufficiently informative. The prescribing of antibiotics by medical practitioners has already been found to contribute to resistance development in a range of pathogenic and commensal organisms, including those in the oral flora.1 If doctors are consulted frequently regarding dental infections, and are therefore prescribing for these infections, the effect of dental prescribing on the development of antimicrobial resistance in the oral flora may be less significant than the evidence suggests. Furthermore, as the antibiotics that dentists prescribe are used for treatment of infections other than those associated with the oral cavity, the prescribing of these drugs by medical practitioners will provide a further selective pressure for resistance. Additionally, as medical practitioners are not expert in the treatment of dental problems, it would not be surprising to find them prescribing inappropriately for dental infections that may only require surgical or mechanical intervention. Guidelines and education regarding prescribing for dental infections may well need to be targeted to medical practitioners as well as dentists.
The problem of antibiotic resistance in the oral flora requires further investigation. More audits of antibiotic prescribing practice may be helpful, although it must be remembered that prescriptions are an indirect measure of antibiotic consumption and are not a measure of the rate of resistance emergence, which is multifactorial.102 Palmer et al.103 examined the potential of audits to alter prescribing habits. The results were encouraging; the number of prescriptions for antibiotics declined by 42.5% after the initial 6 weeks of the audit. In the first period, 2316 prescriptions were issued; this fell to 1330 after educational meetings half way through the process. Thus, there was a significant change in the appropriateness of prescribing during the study.103 The audit and the resulting guidelines, and educational meetings addressing the problems revealed by the audit, were therefore found to be effective, at least in the short term.
In May 1997, Health Canada and the Canadian Infectious Disease Society held a national conference in Montreal entitled Controlling antimicrobial resistance: an integrated action plan for Canadians. The aim was to develop a plan to limit the development of antimicrobial resistance and its spread.104 Dental practitioners were represented at the conference and a number of recommendations were made, to be implemented by all practitioners prescribing antibiotics. One was the establishment of a surveillance system to determine the extent of resistance and to monitor the use of antibiotics.104 Currently, there is no surveillance system in the UK that monitors resistance in the oral flora. Surveillance may be used to monitor the susceptibility of microorganisms and to detect any changes in that susceptibility.105 It may also provide information that will allow the formulation of strategies to combat antimicrobial resistance, including policy changes, formulary changes and alteration of prescribing practices. It may also be used to assess the impact of any strategies on resistance selection and transmission. Resistance trends, including the most prevalent mechanisms of resistance and their transmission, may also be determined from surveillance data.105107
The diagnostic microbiology laboratory has a significant role to play in surveillance, through identification of organisms with a pathogenic role in infection, and their subsequent susceptibility testing. It is therefore important to establish better awareness and communication between general dental practitioners and diagnostic microbiology laboratories. Information obtained from microbiological testing must be collated and disseminated rapidly to health care professionals and other appropriate groups for it to be employed usefully. Local surveillance networks are most important for guiding clinicians in the use of empirical therapy and managing resistant infections.108 It is important to include all health professionals in such networks.
Strains of bacteria resistant to antibiotics are present within the oral flora in sufficient quantities to warrant further investigation. There is evidence that inappropriate prescribing by dental practitioners may be contributing to the development of this resistance. If so, then the dental profession must take steps to prevent the problem from becoming worse. Comprehensive undergraduate and postgraduate education on the subject is required. Further studies and establishment of a surveillance system are also to be recommended. Clear guidelines and prescribing policies need to be developed to attempt to limit resistance within the oral flora. Antibiotic use by dentists affects flora that exist beyond the oral cavity, since, during therapy, antibiotics become distributed throughout the body. Antibiotics prescribed by medical practitioners also have similar broad effects. If dentists, along with medical practitioners, can reduce the number of antibiotic prescriptions, the rate of resistance development may be slowed.
There is reason for concern regarding antibiotic resistance in dental practice. The installation of a surveillance system, accompanied by audit to ascertain the numbers of prescriptions written and their appropriateness, to highlight areas of prescribing knowledge that are lacking in dental practice are recommended. Further investigation and education are required to attempt to slow resistance development and lessen the future impact on antibiotic prescribing in dentistry. The emergence of antibiotic-resistant bacteria within the oral flora will have an impact on the prescribing of antibiotics in dentistry. Action must be taken now to lessen this impact in the future.
![]() |
Acknowledgements |
---|
![]() |
Footnotes |
---|
![]() |
References |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
2
.
Austin, D. J., Kristinsson, K. G. & Anderson, R. M. (1999). The relationship between the volume of antimicrobial consumption in human communities and the frequency of resistance. Proceedings of the National Academy of Sciences, USA 96, 11526.
3 . OConnor, B. C., Newman, H. N. & Wilson, M. (1990). Susceptibility and resistance of plaque bacteria to minocycline. Journal of Periodontology 61, 22833.[ISI][Medline]
4 . Stjernquist-Desatnik, A., Samuelsson, P. & Walder, M. (1993). Penetration of penicillin V to tonsillar surface fluid in healthy individuals and in patients with acute tonsillitis. Journal of Laryngology and Otology 107, 30912.[ISI][Medline]
5 . Nelson, J. D., Ginsburg, C. M., McLeland, O. et al. (1981). Concentrations of antimicrobial agents in middle ear fluid, saliva and tears. International Journal of Pediatric Otorhinolaryngology 3, 32734.[ISI][Medline]
6 . Henry, J., Turner, P., Garland, M. et al. (1980). Plasma and salivary concentrations of erythromycin after administration of three different formulations. Postgraduate Medical Journal 56, 70710.[Abstract]
7 . Ducci, M., Scalori, V., del Tacca, M. et al. (1981). The pharmacokinetics of two erythromycin esters in plasma and in saliva following oral administration in humans. International Journal of Clinical Pharmacology, Therapy and Toxicology 19, 4947.[Medline]
8 . Malizia, T., Tejada, M. R., Ghelardi, E. et al. (1997). Periodontal tissue disposition of azithromycin. Journal of Periodontology 68, 12069.[ISI][Medline]
9 . Blandizzi, C., Malizia, T., Lupetti, A. et al. (1999). Periodontal tissue disposition of azithromycin in patients affected by chronic inflammatory periodontal diseases. Journal of Periodontology 70, 9606.[ISI][Medline]
10 . Malizia, T., Batoni, G., Ghelardi, E. et al. (2001). Interaction between piroxicam and azithromycin during distribution to human periodontal tissues. Journal of Periodontology 72, 11516.[ISI][Medline]
11
.
Priest, P., Yudkin, P., McNulty, C. et al. (2001). Antibacterial prescribing and antibacterial resistance in English general practice: cross sectional study. British Medical Journal 323, 103741.
12 . Carrie, A. G. & Zhanel, G. G. (1999). Antibacterial use in community practice Assessing quantity, indications and appropriateness, and relationship to the development of antibacterial resistance. Drugs 57, 87181.[ISI][Medline]
13 . Liljemark, W. F. & Bloomquist, C. (1996). Human oral microbial ecology and dental caries and periodontal diseases. Critical Reviews in Oral Biology and Medicine 7, 18098.[Medline]
14 . Theilade, E., Fejerskov, O., Karring, T. et al. (1982). Predominant cultivable microflora of human dental fissure plaque. Infection and Immunity 36, 97782.[ISI][Medline]
15 . Wilson, M. J., Weightman, A. J. & Wade, W. G. (1997). Applications of molecular ecology in the characterization of uncultured microorganisms associated with human disease. Reviews in Medical Microbiology 8, 91101.[ISI]
16
.
Paster, B. J., Boches, S. K., Galvin, J. L. et al. (2001). Bacterial diversity in human subgingival plaque. Journal of Bacteriology 183, 377083.
17
.
Facklam, R. (2002). What happened to the streptococci: overview of taxonomic and nomenclature changes. Clinical Microbiology Reviews 15, 61330.
18 . Fine, D. H., Hammond, B. F. & Loesche, W. J. (1998). Clinical use of antibiotics in dental practice. International Journal of Antimicrobial Agents 9, 2358.[CrossRef][ISI][Medline]
19 . Thomas, D. W., Satterthwaite, J., Absi, E. G. et al. (1996). Antibiotic prescription for acute dental conditions in the primary care setting. British Dental Journal 181, 4014.[ISI][Medline]
20 . Roy, K. M. & Bagg, J. (2000). Antibiotic prescribing by general dental practitioners in the Greater Glasgow Health Board, Scotland. British Dental Journal 188, 6746.[CrossRef][ISI][Medline]
21
.
Palmer, N. O. A., Martin, M. V., Pealing, R. et al. (2000). An analysis of antibiotic prescriptions from general dental practitioners in England. Journal of Antimicrobial Chemotherapy 46, 10335.
22 . Palmer, N. A. O., Pealing, R., Ireland, R. S. et al. (2000). A study of prophylactic antibiotic prescribing in National Health Service general dental practice in England. British Dental Journal 189, 436.[CrossRef][ISI][Medline]
23 . Handal, T. & Olsen, I. (2000). Antimicrobial resistance with focus on oral ß-lactamases. European Journal of Oral Sciences 108, 16374.[CrossRef][ISI][Medline]
24 . Lana, M. A., Ribeiro-Sobrinho, A. P., Stehling, R. et al. (2001). Microorganisms isolated from root canals presenting necrotic pulp and their drug susceptibility in vitro. Oral Microbiology and Immunology 16, 1005.[CrossRef][ISI][Medline]
25 . Fosse, T., Madinier, I., Hitzig, C. et al. (1999). Prevalence of ß-lactamase-producing strains among 149 anaerobic Gram-negative rods isolated from periodontal pockets. Oral Microbiology and Immunology 14, 3527.[CrossRef][ISI][Medline]
26 . Kinder, S. A., Holt, S. C. & Korman, K. S. (1986). Penicillin resistance in the subgingival microbiota associated with adult periodontitis. Journal of Clinical Microbiology 23, 112733.[ISI][Medline]
27 . Chambers, H. F. (1999). Penicillin-binding protein-mediated resistance in pneumococci and staphylococci. Journal of Infectious Diseases 179, S3539.[ISI][Medline]
28 . Cvitkovitch, D. G. (2001). Genetic competence and transformation in oral streptococci. Critical Reviews in Oral Biology and Medicine 12, 21743.[Medline]
29 . Hakenbeck, R. (1998). Mosaic genes and their role in penicillin-resistant Streptococcus pneumoniae. Electrophoresis 19, 597601.[ISI][Medline]
30 . Teng, L. J., Hsueh, P. R., Chen, Y. C. et al. (1998). Antimicrobial susceptibility of viridans group streptococci in Taiwan with an emphasis on the high rates of resistance to penicillin and macrolides in Streptococcus oralis. Journal of Antimicrobial Chemotherapy 41, 6217.[Abstract]
31 . Potgieter, E., Carmichael, M., Koornhof, H. J. et al. (1992). In vitro antimicrobial susceptibility of viridans streptococci isolated from blood cultures. European Journal of Clinical Microbiology and Infectious Diseases 11, 5436.[ISI][Medline]
32 . Baker, C. N. & Thornsberry, C. (1974). Antimicrobial susceptibility of Streptococcus mutans isolated from patients with endocarditis. Antimicrobial Agents and Chemotherapy 5, 26871.[ISI][Medline]
33
.
Leistevuo, J., Jarvinen, H., Osterblad, M. et al. (2000). Resistance to mercury and antimicrobial agents in Streptococcus mutans isolates from human subjects in relation to exposure to dental amalgam fillings. Antimicrobial Agents and Chemotherapy 44, 4567.
34 . Jarvinen, H., Pienihakkinen, K., Huovinen, P. et al. (1995). Susceptibility of Streptococcus mutans and Streptococcus sobrinus to antimicrobial agents after short-term oral chlorhexidine treatments. European Journal of Oral Sciences 103, 325.[ISI][Medline]
35 . Jarvinen, H., Tenovuo, J. & Huovinen, P. (1993). In vitro susceptibility of Streptococcus mutans to chlorhexidine and 6 other antimicrobial agents. Antimicrobial Agents and Chemotherapy 37, 11589.[Abstract]
36 . Ekstrand, J., Bjorkman, L., Edlund, C. et al. (1998). Toxicological aspects of the release and systemic uptake of mercury from dental amalgam. European Journal of Oral Sciences 106, 67886.[CrossRef][ISI][Medline]
37 . Wahl, M. J. (2001). Amalgam resurrection and redemption. Part 2: The medical mythology of anti-amalgam. Quintessence International 32, 696710.[ISI][Medline]
38 . Reichmann, P., Konig, A., Linares, J. et al. (1997). A global gene pool for high-level cephalosporin resistance in commensal Streptococcus species and Streptococcus pneumoniae. Journal of Infectious Diseases 176, 100112.[ISI][Medline]
39 . Konig, A., Reinert, R. R. & Hakenbeck, R. (1998). Streptococcus mitis with unusually high level resistance to ß-lactam antibiotics. Microbial Drug Resistance 4, 459.[ISI][Medline]
40 . Dowson, C. G., Hutchison, A., Woodford, N. et al. (1990). Penicillin-resistant viridans streptococci have obtained altered penicillin-binding protein genes from penicillin-resistant strains of Streptococcus pneumoniae. Proceedings of the National Academy of Sciences, USA 87, 585862.[Abstract]
41 . Coffey, T. J., Dowson, C. G., Daniels, M. et al. (1993). Horizontal spread of an altered Penicillin-Binding Protein 2b gene between Streptococcus pneumoniae and Streptococcus oralis. FEMS Microbiology Letters 110, 3359.[CrossRef][ISI][Medline]
42 . Potgieter, E. & Chalkley, L. J. (1995). Relatedness among penicillin-binding protein 2b genes of Streptococcus mitis, Streptococcus oralis, and Streptococcus pneumoniae. Microbial Drug Resistance 1, 3542.[ISI][Medline]
43 . Hakenbeck, R. (1995). Target-mediated resistance to ß-lactam antibiotics. Biochemical Pharmacology 50, 11217.[CrossRef][ISI][Medline]
44 . Kuriyama, T., Karasawa, T., Nakagawa, K. et al. (2002). Antimicrobial susceptibility of major pathogens of orofacial odontogenic infections to 11 ß-lactam antibiotics. Oral Microbiology and Immunology 17, 2859.[CrossRef][ISI][Medline]
45 . Jacobs, M. R., Spangler, S. K. & Appelbaum, P. C. (1992). ß-Lactamase production and susceptibility of US and European anaerobic Gram-negative bacilli to ß-lactams and other agents. European Journal of Clinical Microbiology and Infectious Diseases 11, 108193.[ISI][Medline]
46 . Kononen, E., Nyfors, S., Matto, J. et al. (1997). ß-lactamase production by oral pigmented Prevotella species isolated from young children. Clinical Infectious Diseases 25, S2724.[ISI][Medline]
47
.
Andres, M. T., Chung, W. O., Roberts, M. C. et al. (1998). Antimicrobial susceptibilities of Porphyromonas gingivalis, Prevotella intermedia, and Prevotella nigrescens spp. isolated in Spain. Antimicrobial Agents and Chemotherapy 42, 30223.
48 . van Winkelhoff, A. J., Winkel, E. G., Barendregt, D. et al. (1997). ß-Lactamase producing bacteria in adult periodontitis. Journal of Clinical Periodontology 24, 53843.[ISI][Medline]
49 . Valdes, M. V., Lobbins, P. M. & Slots, J. (1982). ß-lactamase producing bacteria in the human oral cavity. Journal of Oral Pathology 11, 5863.[ISI][Medline]
50 . Eick, S., Pfister, W. & Straube, E. (1999). Antimicrobial susceptibility of anaerobic and capnophilic bacteria isolated from odontogenic abscesses and rapidly progressive periodontitis. International Journal of Antimicrobial Agents 12, 416.[CrossRef][ISI][Medline]
51 . Sandor, G. K., Low, D. E., Judd, P. L. et al. (1998). Antimicrobial treatment options in the management of odontogenic infections. Journal of the Canadian Dental Association 64, 50814.[Medline]
52 . Trinh, S., Haggoud, A. & Reysset, G. (1996). Conjugal transfer of the 5-nitroimidazole resistance plasmid pIP417 from Bacteroides vulgatus BV-17: characterization and nucleotide sequence analysis of the mobilization region. Journal of Bacteriology 178, 66716.[Abstract]
53 . Roberts, M. C. (2000). Antibiotic toxicity, interactions and resistance development. Periodontology 28, 28097.[CrossRef]
54 . Roche, Y. & Yoshimori, R. N. (1997). In vitro activity of spiramycin and metronidazole alone or in combination against clinical isolates from odontogenic abscesses. Journal of Antimicrobial Chemotherapy 40, 3537.[Abstract]
55 . Madinier, I. M., Fosse, T. B., Hitzig, C. et al. (1999). Resistance profile survey of 50 periodontal strains of Actinobacillus actinomycetemcomitans. Journal of Periodontology 70, 88892.[ISI][Medline]
56
.
Sandoe, J. A., Struthers, J. K. & Brazier, J. S. (2001). Subdural empyema caused by Prevotella loescheii with reduced susceptibility to metronidazole. Journal of Antimicrobial Chemotherapy 47, 3667.
57
.
Owen, R. J. (2002). Molecular testing for antibiotic resistance in Helicobacter pylori. Gut 50, 2859.
58
.
Upcroft, P. & Upcroft, J. A. (2001). Drug targets and mechanisms of resistance in the anaerobic protozoa. Clinical Microbiology Reviews 14, 15064.
59 . Noda, M., Komatsu, H., Inoue, S. et al. (2000). Antibiotic susceptibility of bacteria detected from the root canal exudate of persistent apical periodontitis. Journal of Endodontics 26, 2214.[ISI][Medline]
60 . Jacobson, J. J., Patel, B., Asher, G. et al. (1997). Oral staphylococcus in older subjects with rheumatoid arthritis. Journal of the American Geriatrics Society 45, 5903.[ISI][Medline]
61 . Rossi, T., Laine, J., Eerola, E. et al. (1995). Denture carriage of methicillin-resistant Staphylococcus aureus. Lancet 345, 1577.
62
.
Smith, A. J., Jackson, M. S. & Bagg, J. (2001). The ecology of Staphylococcus species in the oral cavity. Journal of Medical Microbiology 50, 9406.
63 . Ioannidou, S., Tassios, P. T., Kotsovili-Tseleni, A. et al. (2001). Antibiotic resistance rates and macrolide resistance phenotypes of viridans group streptococci from the oropharynx of healthy Greek children. International Journal of Antimicrobial Agents 17, 195201.[CrossRef][ISI][Medline]
64 . Okamoto, M., Takano, K. & Maeda, N. (2001). Distribution of the tetracycline resistance determinant tetQ gene in oral isolates of black-pigmented anaerobes in Japan. Oral Microbiology and Immunology 16, 2248.[CrossRef][ISI][Medline]
65 . Sanai, Y., Persson, G. R., Starr, J. R. et al. (2002). Presence and antibiotic resistance of Porphyromonas gingivalis, Prevotella intermedia, and Prevotella nigrescens in children. Journal of Clinical Periodontology. 29, 92934.[CrossRef][ISI][Medline]
66 . Nikolich, M. P., Hong, G., Shoemaker, N. B. et al. (1994). Evidence for natural horizontal transfer of tetQ between bacteria that normally colonize humans and bacteria that normally colonize livestock. Applied and Environmental Microbiology 60, 325560.[Abstract]
67 . Olsvik, B., Olsen, I. & Tenover, F. C. (1994). The tet(Q) gene in bacteria isolated from patients with refractory periodontal disease. Oral Microbiology and Immunology 9, 2515.[ISI][Medline]
68 . Teanpaisan, R., Douglas, C. W., Eley, A. R. et al. (1996). Clonality of Porphyromonas gingivalis, Prevotella intermedia and Prevotella nigrescens isolated from periodontally diseased and healthy sites. Journal of Periodontal Research 31, 42332.[ISI][Medline]
69 . Chung, W. S. O., Gabany, J., Persson, G. R. et al. (2002). Distribution of erm(F) and tet(Q) genes in 4 oral bacterial species and genotypic variation between resistant and susceptible isolates. Journal of Clinical Periodontology 29, 1528.[CrossRef][ISI][Medline]
70 . Guiney, D. G. & Bouic, K. (1990). Detection of conjugal transfer systems in oral, black-pigmented Bacteroides spp. Journal of Bacteriology 172, 4957.[ISI][Medline]
71 . Lacroix, J. M. & Walker, C. B. (1996). Detection and prevalence of the tetracycline resistance determinant Tet Q in the microbiota associated with adult periodontitis. Oral Microbiology and Immunology 11, 2828.[ISI][Medline]
72 . van der Bijl, P. & Pitigoi-Aron, G. (1995). Tetracyclines and calcified tissues. Annals of Dentistry 54, 6972.[Medline]
73 . Walker, C. B., Gordon, J. M. & Socransky, S. S. (1983). Antibiotic susceptibility testing of subgingival plaque samples. Journal of Clinical Periodontology 10, 42232.[ISI][Medline]
74
.
Ready, D., Roberts, A. P., Pratten, J. et al. (2002). Composition and antibiotic resistance profile of microcosm dental plaques before and after exposure to tetracycline. Journal of Antimicrobial Chemotherapy 49, 76975.
75 . Ready, D., Qureshi, F., Bedi, R. et al. (2003). Oral bacteria resistant to mercury and to antibiotics are present in children with no previous exposure to amalgam restorative materials. FEMS Microbiology Letters 223, 10711.[CrossRef][ISI][Medline]
76 . King, A., Bathgate, T. & Phillips, I. (2002). Erythromycin susceptibility of viridans streptococci from the normal throat flora of patients treated with azithromycin or clarithromycin. Clinical Microbiology and Infection 8, 8592.[CrossRef][ISI][Medline]
77
.
Arpin, C., Canron, M. H., Noury, P. et al. (1999). Emergence of mefA and mefE genes in ß-haemolytic streptococci and pneumococci in France. Journal of Antimicrobial Chemotherapy 44, 1334.
78 . Sefton, A. M. (1999). Macrolides and changes in the oral flora. International Journal of Antimicrobial Agents 11, S239; discussion S312.[CrossRef][ISI]
79 . Emilson, C. G. & Westergren, G. (1979). Effect of chlorhexidine on the relative proportions of Streptococcus mutans and Streptococcus sanguis in hamster plaque. Scandinavian Journal of Dental Research 87, 28895.[ISI][Medline]
80 . Westergren, G. & Emilson, C. G. (1980). In vitro development of chlorhexidine resistance in Streptococcus sanguis and its transmissibility by genetic transformation. Scandinavian Journal of Dental Research 88, 23643.[ISI][Medline]
81 . Yamamoto, T., Tamura, Y. & Yokota, T. (1988). Antiseptic and antibiotic resistance plasmid in Staphylococcus aureus that possesses ability to confer chlorhexidine and acrinol resistance. Antimicrobial Agents and Chemotherapy 32, 9325.[ISI][Medline]
82 . Dental Practice Board. (1998). Digest of Statistics, 1996/97, Part 1: Detailed Analysis of GDS Treatment Items, Eastbourne. Dental Practice Board, Eastbourne, UK.
83 . British Dental Association; British Medical Association; Royal Pharmaceutical Society of Great Britain. (2001). Dental Practitioners Formulary. British Medical Association and the Royal Pharmaceutical Society of Great Britain, London, UK.
84 . Barker, G. R. & Qualtrough, A. J. E. (1987). An Investigation into antibiotic prescribing at a dental teaching hospital. British Dental Journal 162, 3036.[CrossRef][ISI][Medline]
85 . Cawson, R. A. & Spector, R. G. (1985). Clinical Pharmacology in Dentistry, 4th edn. Churchill Livingstone, Edinburgh, UK.
86 . Longman, L. P., Preston, A. J., Martin, M. V. et al. (2000). Endodontics in the adult patient: the role of antibiotics. Journal of Dentistry 28, 53948.[CrossRef][ISI][Medline]
87 . Samaranayake, L. P. & Johnson, N. W. (1999). Guidelines for the use of antimicrobial agents to minimise development of resistance. International Dental Journal 49, 18995.[ISI][Medline]
88 . Amsden, G. W., Ballow, C. H. & Bertino, J. S. (1994). Pharmacokinetics and pharmacodynamics of anti-infective agents. In Principles and Practice of Infectious Diseases, 4th edn (Mandell, G. L., Bennett, J. E. & Dolin, R., Eds), pp. 25361. Churchill Livingstone, Philadelphia, PA, USA.
89
.
Lonks, J. R., Dickinson, B. P. & Runarsdottir, V. (1999). Endocarditis due to Streptococcus mitis with high-level resistance to penicillin and cefotaxime. New England Journal of Medicine 341, 1239.
90 . Reichmann, P., Konig, A., Marton, A. et al. (1996). Penicillin-binding proteins as resistance determinants in clinical isolates of Streptococcus pneumoniae. Microbial Drug Resistance 2, 17781.[ISI][Medline]
91 . Alcaide, F., Carratala, J., Linares, J. et al. (1996). In vitro activities of eight macrolide antibiotics and RP-59500 (quinupristindalfopristin) against viridans group streptococci isolated from blood of neutropenic cancer patients. Antimicrobial Agents and Chemotherapy 40, 211720.[Abstract]
92 . American Heart Association. (1997). Prevention of bacterial endocarditis: recommendations. Journal of the American Dental Association 128, 114251.[ISI][Medline]
93 . Longman, L. P. & Martin, M. V. (1991). The use of antibiotics in the prevention of post-operative infection: a re-appraisal. British Dental Journal 170, 25762.[ISI][Medline]
94 . Slots, J. & Pallasch, T. J. (1996). Dentists role in halting antimicrobial resistance. [erratum appears in Journal of Dental Research 75, 1811]. Journal of Dental Research 75, 133841.[ISI][Medline]
95 . Simmons, N. A., Ball, A. P., Cawson, R. A. et al. (1992). Case against antibiotic prophylaxis for dental treatment of patients with joint prostheses. Lancet 339, 301.[ISI][Medline]
96 . Pallasch, T. J. & Slots, J. (2000). Antibiotic prophylaxis and the medically compromised patient. Periodontology 10, 10738.
97 . Anderson, R., Calder, L. & Thomas, D. W. (2000). Antibiotic prescribing for dental conditions: general medical practitioners and dentists compared. British Dental Journal 188, 398400.[CrossRef][ISI][Medline]
98 . Roy, K. M., Smith, A., Sanderson, J. et al. (1999). Barriers to the use of a diagnostic oral microbiology laboratory by general dental practitioners. British Dental Journal 186, 3457.[CrossRef][ISI][Medline]
99
.
Palmer, N. O. A., Martin, M. V., Pealing, R. et al. (2001). Antibiotic prescribing knowledge of national health service general dental practitioners in England and Scotland. Journal of Antimicrobial Chemotherapy 47, 2337.
100 . Barbosa, F. C. B., Mayer, M. P. A., Saba-Chujfi, E. et al. (2001). Subgingival occurrence and antimicrobial susceptibility of enteric rods and pseudomonads from Brazilian periodontitis patients. Oral Microbiology and Immunology 16, 30610.[CrossRef][ISI][Medline]
101 . American Dental Association. (1997). Antibiotic use in dentistry. Journal of the American Dental Association 128, 648.[ISI][Medline]
102 . Heritage, J., Wilcox, M. & Sandoe, J. (2001). Antimicrobial resistance potential. Lancet 358, 1099100.
103 . Palmer, N. A. O., Dailey, Y. M. & Martin, M. V. (2001). Can audit improve antibiotic prescribing in general dental practice? British Dental Journal 191, 2535.[ISI][Medline]
104 . Haas, D. A., Epstein, J. B. & Eggert, F. M. (1998). Antimicrobial resistance: dentistrys role. Journal of the Canadian Dental Association 64, 496502.[Medline]
105 . Bax, R., Bywater, R., Cornaglia, G. et al. (2001). Surveillance of antimicrobial resistance what, how and whither? Clinical Microbiology and Infection 7, 31625.[CrossRef][ISI][Medline]
106 . Karlowsky, J. A. & Sahm, D. F. (2002). Antibiotic resistance is resistance detected by surveillance relevant to predicting resistance in the clinical setting? Current Opinion in Pharmacology 2, 48792.[CrossRef][ISI][Medline]
107 . Finch, R. (2002). Antibiotic resistance from pathogen to disease surveillance. Clinical Microbiology and Infection 8, 31720.[CrossRef][ISI][Medline]
108
.
Livermore, D. M., MacGowan, A. P. & Wale, M. C. (1998). Surveillance of antimicrobial resistance. centralised surveys to validate routine data offer a practical approach. British Medical Journal 317, 6145.
|